Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001292
Filing Date
2017-03-06
Accepted
2017-03-06 16:09:04
Documents
108
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231138z10-k.htm 10-K 1743426
2 EX-23.1 a2231138zex-23_1.htm EX-23.1 2757
3 EX-31.1 a2231138zex-31_1.htm EX-31.1 7760
4 EX-31.2 a2231138zex-31_2.htm EX-31.2 7779
5 EX-32.1 a2231138zex-32_1.htm EX-32.1 4944
12 G688763.JPG g688763.jpg GRAPHIC 95128
13 G642250.JPG g642250.jpg GRAPHIC 33199
14 G168698.JPG g168698.jpg GRAPHIC 63318
15 G301220.JPG g301220.jpg GRAPHIC 69709
16 G626229.JPG g626229.jpg GRAPHIC 46050
17 G866194.JPG g866194.jpg GRAPHIC 63529
18 G574546.JPG g574546.jpg GRAPHIC 48010
19 G828777.JPG g828777.jpg GRAPHIC 93761
20 G209509.JPG g209509.jpg GRAPHIC 35549
  Complete submission text file 0001047469-17-001292.txt   10351124

Data Files

Seq Description Document Type Size
6 EX-101.INS rarx-20161231.xml EX-101.INS 2321256
7 EX-101.SCH rarx-20161231.xsd EX-101.SCH 77234
8 EX-101.CAL rarx-20161231_cal.xml EX-101.CAL 65571
9 EX-101.LAB rarx-20161231_lab.xml EX-101.LAB 637529
10 EX-101.PRE rarx-20161231_pre.xml EX-101.PRE 556516
11 EX-101.DEF rarx-20161231_def.xml EX-101.DEF 333269
Mailing Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

EIN.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37926 | Film No.: 17667942
SIC: 2834 Pharmaceutical Preparations